OTCMKTS:PCHM PharmChem (PCHM) Stock Price, News & Analysis $3.75 0.00 (0.00%) As of 09/25/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartDividend About PharmChem Stock (OTCMKTS:PCHM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PharmChem alerts:Sign Up Key Stats Today's Range$3.75▼$3.7550-Day Range$3.75▼$3.7552-Week Range$2.95▼$3.98VolumeN/AAverage Volume7,005 shsMarket Capitalization$17.43 millionP/E Ratio15.63Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview PharmChem, Inc. is a biotechnology and drug-testing company that develops, manufactures and markets products used to detect drugs of abuse. Its principal product is the PharmChek Sweat Patch, a tamper-resistant collection device designed to gather perspiration over an extended monitoring period for laboratory analysis. The company’s products are intended for use in substance-abuse monitoring and drug-testing programs. Applications include criminal justice and corrections, child welfare, treatment and rehabilitation programs, and workplace testing. The sweat-patch format provides an alternative to more conventional specimen-collection methods by enabling continuous monitoring during the period in which the patch is worn. PharmChem has historically focused on specialized drug-testing technology and related laboratory analysis rather than consumer healthcare products. Publicly available information about its current leadership, geographic footprint and broader operations is limited.AI Generated. May Contain Errors. Read More Receive PCHM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PharmChem and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PCHM Stock News HeadlinesPharmChem, Inc. Announces Shareholder Approval of Acquisition by Alcohol Monitoring Systems, Inc.August 27, 2025 | prnewswire.comShareholder Alert: The Ademi Firm investigates whether PharmChem, Inc. is obtaining a Fair Price for its Public ShareholdersJuly 21, 2025 | prnewswire.comBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going to hell." Ray Dalio agrees. The founder of Bridgewater Associates ($150 billion AUM) calls it a "debt death spiral." But there's a specific asset class and investment system that actually thrives when the dollar collapses.September 26 at 1:00 AM | Decentralized Masters (Ad)PharmChem, Inc. Announces Acquisition by Alcohol Monitoring Systems, Inc.July 21, 2025 | prnewswire.comPharmChem, Inc. (PCHM) - Yahoo FinanceJune 26, 2025 | nz.finance.yahoo.comPharmChem, Inc. (PCHM) stock price, news, quote & history - Yahoo FinanceJune 26, 2025 | au.finance.yahoo.comPharmChem, Inc. (PCHM) Latest Press Releases & Corporate News - Yahoo FinanceApril 29, 2025 | finance.yahoo.comPharmChem (OTC:PCHM) Stock Quotes, Forecast and News SummaryFebruary 9, 2025 | benzinga.comSee More Headlines PCHM Stock Analysis - Frequently Asked Questions How have PCHM shares performed this year? PharmChem's stock was trading at $3.75 on January 1st, 2026. Since then, PCHM stock has increased by 0.0% and is now trading at $3.75. How were PharmChem's earnings last quarter? PharmChem Inc. (OTCMKTS:PCHM) posted its quarterly earnings data on Thursday, August, 7th. The company reported $0.04 earnings per share for the quarter. The firm had revenue of $1.56 million for the quarter. How do I buy shares of PharmChem? Shares of PCHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/07/2025Today9/26/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry MED - OUTP/HM CRE Sub-IndustryHealthcare Current SymbolOTCMKTS:PCHM CIKN/A Webwww.pharmchek.com Phone(855) 458-4100Fax817-605-6400Employees170Year FoundedN/AProfitability EPS (Trailing Twelve Months)$0.24 Trailing P/E Ratio15.63 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.38 million Net Margins17.92% Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$6.09 million Price / Sales2.86 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares4,648,000Free Float3,839,000Market Cap$17.43 million OptionableNot Optionable Beta0.61 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:PCHM) was last updated on 9/26/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredThe No. 1 move you need to make before Musk’s “Starphone” goes mainstreamTech forecaster Josh Baylin, who briefed Congress on the iPhone years before its release, says Elon Musk is bu...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmChem Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmChem With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
